We chose to include only one variable from each of the categories (baseline amyloid PET, plasma, tau PET, cognition, function) to predict cognitive decline to avoid overfitting the models but will continue to explore additional variables from these modalities. The gene discussed is MAPT; the disease is Mental deterioration.